New therapy helps veterans with PTSD by targeting 'Safety Behaviors'

NCT ID NCT04515784

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a 10-week group therapy program called START-PTSD for 45 veterans with PTSD who had declined standard trauma-focused treatment. The therapy helps veterans identify and gradually reduce 'safety aids'—behaviors like avoiding certain places or using mental distractions that keep fear alive. Researchers measured changes in PTSD symptoms, safety aid use, and treatment satisfaction immediately after the program and one month later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Safety Aid Reduction Treatment (START-PTSD) - a behavioral therapy that helps veterans identify and reduce safety behaviors (like avoidance) that maintain PTSD symptoms.
What this could lead to
If this treatment works, it could offer a new option for veterans with PTSD who are unwilling or unable to undergo traditional trauma-focused therapy, potentially reducing their symptoms and improving daily functioning.
What could go wrong
This was a small, early-phase study with only 45 participants, so results may not apply to all veterans. The treatment is behavioral and may not work for everyone, and there is a risk that symptoms could worsen temporarily when safety aids are removed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STRESS DISORDERS, POST-TRAUMATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Southeast Louisiana Veterans Health Care System, New Orleans, LA

    New Orleans, Louisiana, 70119, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.